 | Up a level |
Varum, F; Thorne, H; Bravo, R; Gilgen, D; Hartig, C; Nicolas, G P; Wild, D; Liakoni, Ev; Haschke, M (2022). Targeted colonic release formulations of mesalazine - A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis. International journal of pharmaceutics, 625, p. 122055. Elsevier 10.1016/j.ijpharm.2022.122055
Cuthbertson, D J; Banks, M; Khoo, B; Antwi, K; Christ, Emanuel; Campbell, F; Raraty, M; Wild, D (2015). Application of Ga(68) -DOTA-exendin-4 PET/CT to localise an occult insulinoma. Clinical endocrinology, 84(5), pp. 789-791. Blackwell Scientific Publications 10.1111/cen.12973
Wild, D; Reubi, JC (2011). Localisation d'in insulinome bénin par imagerie des récepteurs du glucagon-like peptide-1. Correspondances en MHDN - métabolismes hormones diabètes & nutrition, 8, pp. 296-297. Courbevoie (F): Edimark
Wild, D; Christ, E; Gloor, B; Mäcke, H; Reubi, JC (2008). Nuklearmedizin: Neue nuklearmedizinische Bildgebung zur Lokalisation von okkulten Insulinomen. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 8(51-52), pp. 1009-1010. Basel: EMH Editores Medicorum Helveticorum
